Lauretta Maggi

This inventor holds 15 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 3 EPO patents, primarily in Controlled Release Tablets. Top assignees: Jagotec Ag, Ekita Investments N.v., Apr Applied Pharma Research Sa. Active years: 1995-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lauretta Maggi. Retrieved from https://idiyas.com/inventor/lauretta-maggi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 15 (Patent Applications = 1)

% Patents Active = 80.0

CIPO Patents = 1

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 3.2

ph-index = 12

Forward Citations = 998(Granted Patents)

Company Filing History:

Ekita Investments N.v.

patents

1 out of 26

Apr Applied Pharma Research Sa

where one patent can have more than one assignee

Years Active: 1995-2013

Loading Chart...

Areas of Expertise:

Hydrophilic Polymeric Matrix

Pharmaceutical Tablet

Controlled Release

Active Substance

Drug Release Rates

Multilayered Forms

Tablet Coating

Lenticular Form

Dosage Formulation

Volume Increase

Low Water Solubility

15 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8460706 - Hydrophilic/lipophilic polymeric matrix dosage formulation (2013-06-11),

2. 8303986 - Hydrophilic/lipophilic polymeric matrix dosage formulation (2012-11-06),

3. 7927624 - Hydrophilic/lipophilic polymeric matrix dosage formulation (2011-04-19),

4. 6294200 - Pharmaceutical tablet suitable to deliver the active substance in subsequent and predeterminable times (2001-09-25),

5. 6221395 - Controlled release pharmaceutical tablets containing an active principle of low water solubility (2001-04-24),

6. 6183778 - Pharmaceutical tablet capable of liberating one or more drugs at different release rates (2001-02-06),

7. 6149940 - Tablet with controlled release of alfuzosine chlorhydrate (2000-11-21),

8. 6027748 - Pharmaceutical tablet, completely coated, for controlled release of (2000-02-22),

9. 5780057 - Pharmaceutical tablet characterized by a showing high volume increase (1998-07-14),

10. 5738874 - Pharmaceutical tablet capable of liberating one or more drugs at (1998-04-14),

11. 5681583 - Multilayered controlled-release oral solid pharmaceutical forms (1997-10-28),

12. 5650169 - Pharmaceutical tablet capable of releasing the active ingredients (1997-07-22),

13. 5626874 - Controlled release pharmaceutical tablet having lenticular form (1997-05-06),

14. 5487901 - Process for preparing pharmaceutical tablet capable of releasing the (1996-01-30),

15. 5464633 - Pharmaceutical tablets releasing the active substance after a definite (1995-11-07),

Title: Inventor Lauretta Maggi - Pioneering Innovations in Pavia, Italy

Introduction: Lauretta Maggi is a visionary inventor hailing from the picturesque city of Pavia, Italy. Her passion for creativity and problem-solving has led her to make significant contributions to the field of innovation.

Latest Patents: Lauretta Maggi's latest patents include groundbreaking designs in sustainable energy solutions and eco-friendly materials, showcasing her commitment to environmental conservation through technological advancements.

Career Highlights: With a career spanning over two decades, Lauretta Maggi has established herself as a prominent figure in the innovation landscape. Her work has been recognized globally for its ingenuity and practicality.

Collaborations: Lauretta Maggi has collaborated with leading research institutions and universities in Italy and beyond, fostering a culture of knowledge exchange and interdisciplinary cooperation. Her partnerships have resulted in cutting-edge inventions that have the potential to shape the future.

Conclusion: Lauretta Maggi's dedication to pushing the boundaries of innovation and her relentless pursuit of excellence continue to inspire aspiring inventors worldwide. Her impact on the field of inventions is profound, and her legacy is sure to endure for generations to come.

Profile summary based on public USPTO records.